TY - JOUR
T1 - Data describing child development at 6 years after maternal cancer diagnosis and treatment during pregnancy
AU - International Network on Cancer, Infertility and Pregnancy (INCIP)
AU - van Gerwena, Mathilde Mathilde
AU - Vandenbrouckec, Tineke
AU - Verheeckec, Magali
AU - Van Calsteren, Kristel
AU - Halaska, Michael J.
AU - Fumagalli, Monica
AU - Fruscio, Robert
AU - Gandhi, Amarendra
AU - Veening, Margreet
AU - Lagae, Lieven
AU - Ottevanger, Petronella B.
AU - Voigt, Jens Uwe
AU - de Haan, Jorine
AU - Gziri, Mina M.
AU - Maggen, Charlotte
AU - Mertens, Luc
AU - Naulaers, Gunnar
AU - Claes, Laurence
AU - Amant, Frédéric
PY - 2020/10
Y1 - 2020/10
N2 - This manuscript is an accompanying resource of the original research article entitled “Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy” and present data that compare the outcome of 6-year-old-children born to women diagnosed with cancer during pregnancy (with or without treatment during pregnancy) (study group) with children born after an uncomplicated pregnancy (control group). Oncological, obstetrical and neonatal data were collected. Neurodevelopment was examined by clinical evaluation and neuropsychological testing (including intelligence, attention and memory tests) and by general health and behavior questionnaires. Cardiac evaluation included electro- and echocardiography. Univariate analyses of covariance were used to investigate between-group differences. A subgroup analysis was performed in chemotherapy-exposed children versus controls and anthracycline-exposed versus controls. Additionally, the incidence of behaviour problems was compared to matched controls for children whose mothers died and for those with surviving mothers.
AB - This manuscript is an accompanying resource of the original research article entitled “Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy” and present data that compare the outcome of 6-year-old-children born to women diagnosed with cancer during pregnancy (with or without treatment during pregnancy) (study group) with children born after an uncomplicated pregnancy (control group). Oncological, obstetrical and neonatal data were collected. Neurodevelopment was examined by clinical evaluation and neuropsychological testing (including intelligence, attention and memory tests) and by general health and behavior questionnaires. Cardiac evaluation included electro- and echocardiography. Univariate analyses of covariance were used to investigate between-group differences. A subgroup analysis was performed in chemotherapy-exposed children versus controls and anthracycline-exposed versus controls. Additionally, the incidence of behaviour problems was compared to matched controls for children whose mothers died and for those with surviving mothers.
KW - Antineoplastic agents
KW - Child development
KW - Follow-up studies
KW - High-risk
KW - Infant
KW - Pregnancy
KW - Prenatal Exposure Delayed Effects
UR - http://www.scopus.com/inward/record.url?scp=85089998734&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089998734&partnerID=8YFLogxK
U2 - 10.1016/j.dib.2020.106209
DO - 10.1016/j.dib.2020.106209
M3 - Article
AN - SCOPUS:85089998734
VL - 32
JO - Data in Brief
JF - Data in Brief
SN - 2352-3409
M1 - 106209
ER -